Didier Debieuvre

机构：Université de Haute-Alsace, Hôpital Émile-Roux, Centre Hospitalier de Mulhouse, Institut de Recherche en Hématologie et Transplantation, Groupe Hospitalier de la Région de Mulhouse et Sud Alsace · ORCID：0000-0002-8016-7956

发表论文 381 篇 · 总被引 6722 次 · h-index 36

代表论文

• Survival of Patients with Lung Adenocarcinoma Diagnosed in 2000, 2010, and 2020 (2025 · NEJM Evidence · 被引 23)
• Real-world efficacy of the dabrafenib-trametinib (D-T) combination in BRAF V600E-mutated metastatic non-small cell lung cancer (NSCLC): Results from the IFCT-2004 BLaDE cohort (2024 · Lung Cancer · 被引 21)
• LIBELULE: A Randomized Phase III Study to Evaluate the Clinical Relevance of Early Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer (2024 · Journal of Thoracic Oncology · 被引 15)
• Real-life nationwide characteristics and outcomes of small cell lung cancer over the last 20 years: Impact of immunotherapy on overall survival in a real-life setting (2024 · European Journal of Cancer · 被引 11)
• Efficacy of first-line treatments for advanced pulmonary sarcomatoid carcinomas: a real-world analysis (2025 · ESMO Open · 被引 9)
• Clinical characteristics and management of long survivors in extensive stage small cell lung cancer (2025 · Lung Cancer · 被引 9)